Company
Candel Therapeutics, Inc. (CADL)
Standardized SEC financial data for Candel Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001841387 · NASDAQ · Biological Products, (No Diagnostic Substances).
Revenue growth (YoY)
0.0%
Return on equity
-73.5%
Free cash flow
-$38.9M
Debt / equity
0.00×
Current ratio
13.49×
EPS (diluted)
$-0.72
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $125K | $125K | $125K | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.3M | $83.1M | $70.3M | $35.7M | $102.9M | $120.1M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$9.1M | -$22.2M | -$31.4M | -$34.2M | -$27.0M | -$38.3M |
| Capital expenditures |
Get CADL data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CADL/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CADL/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"